Drug · DIN 02555409
NB-RISPERIDONE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 7, 2025.
- Drug Identification Number (DIN)
- 02555409
- Company (DIN owner)
- NB Pharma Inc.Québec, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 7, 2025: NOC 34802Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers.
Other DINs named NB-RISPERIDONE
- DIN 02555352 · Approved
- DIN 02555360 · Approved
- DIN 02555379 · Approved
- DIN 02555387 · Approved
- DIN 02555395 · Approved